EMERGENCY MEDICATIONS

UTI is uncommon with SGLT2i - mycotic infections are common This study has important clinical implications ⚠️ After UTI, 1 in 3 patients stopped SGLT2i Discontinuation led to higher CV & renal risk, with no reduction in recurrent UTIs. 💡 Following UTI - continue SGLT2i

Remember this is for a-fib and that the dose adjustments don’t apply when using for VTE treatment